436 related articles for article (PubMed ID: 29859717)
1. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
Mezzelani M; Gorbi S; Regoli F
Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and ecotoxicological assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic environment?
Desbiolles F; Malleret L; Tiliacos C; Wong-Wah-Chung P; Laffont-Schwob I
Sci Total Environ; 2018 Oct; 639():1334-1348. PubMed ID: 29929299
[TBL] [Abstract][Full Text] [Related]
3. The Biological Effects of Pharmaceuticals in the Marine Environment.
Mezzelani M; Regoli F
Ann Rev Mar Sci; 2022 Jan; 14():105-128. PubMed ID: 34425054
[TBL] [Abstract][Full Text] [Related]
4. Presence of pharmaceuticals and their metabolites in wild-living aquatic organisms - Current state of knowledge.
Świacka K; Maculewicz J; Kowalska D; Caban M; Smolarz K; Świeżak J
J Hazard Mater; 2022 Feb; 424(Pt A):127350. PubMed ID: 34607031
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceuticals and personal care products (PPCPs) in Arctic environments: indicator contaminants for assessing local and remote anthropogenic sources in a pristine ecosystem in change.
Kallenborn R; Brorström-Lundén E; Reiersen LO; Wilson S
Environ Sci Pollut Res Int; 2018 Nov; 25(33):33001-33013. PubMed ID: 28762048
[TBL] [Abstract][Full Text] [Related]
6. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
[TBL] [Abstract][Full Text] [Related]
7. Ecotoxicological potential of non-steroidal anti-inflammatory drugs (NSAIDs) in marine organisms: Bioavailability, biomarkers and natural occurrence in Mytilus galloprovincialis.
Mezzelani M; Gorbi S; Da Ros Z; Fattorini D; d'Errico G; Milan M; Bargelloni L; Regoli F
Mar Environ Res; 2016 Oct; 121():31-9. PubMed ID: 27036085
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceuticals in the marine environment: What are the present challenges in their monitoring?
Branchet P; Arpin-Pont L; Piram A; Boissery P; Wong-Wah-Chung P; Doumenq P
Sci Total Environ; 2021 Apr; 766():142644. PubMed ID: 33077207
[TBL] [Abstract][Full Text] [Related]
9. Factory-discharged pharmaceuticals could be a relevant source of aquatic environment contamination: review of evidence and need for knowledge.
Cardoso O; Porcher JM; Sanchez W
Chemosphere; 2014 Nov; 115():20-30. PubMed ID: 24602347
[TBL] [Abstract][Full Text] [Related]
10. Ranking and prioritizing pharmaceuticals in the aquatic environment of China.
Li Y; Zhang L; Liu X; Ding J
Sci Total Environ; 2019 Mar; 658():333-342. PubMed ID: 30579191
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceuticals in the environment: expected and unexpected effects on aquatic fauna.
Fabbri E
Ann N Y Acad Sci; 2015 Mar; 1340():20-8. PubMed ID: 25557669
[TBL] [Abstract][Full Text] [Related]
12. Bioconcentration, bioaccumulation, and metabolism of pesticides in aquatic organisms.
Katagi T
Rev Environ Contam Toxicol; 2010; 204():1-132. PubMed ID: 19957234
[TBL] [Abstract][Full Text] [Related]
13. Bioaccumulation and analytics of pharmaceutical residues in the environment: A review.
Puckowski A; Mioduszewska K; Łukaszewicz P; Borecka M; Caban M; Maszkowska J; Stepnowski P
J Pharm Biomed Anal; 2016 Aug; 127():232-55. PubMed ID: 26968887
[TBL] [Abstract][Full Text] [Related]
14. Exposure and ecotoxicological risk assessment of mixtures of top prescribed pharmaceuticals in Swedish freshwaters.
Lindim C; de Zwart D; Cousins IT; Kutsarova S; Kühne R; Schüürmann G
Chemosphere; 2019 Apr; 220():344-352. PubMed ID: 30590300
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
Huerta B; Rodríguez-Mozaz S; Barceló D
Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
[TBL] [Abstract][Full Text] [Related]
16. Risk screening of pharmaceutical compounds in Romanian aquatic environment.
Gheorghe S; Petre J; Lucaciu I; Stoica C; Nita-Lazar M
Environ Monit Assess; 2016 Jun; 188(6):379. PubMed ID: 27234514
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
[TBL] [Abstract][Full Text] [Related]
18. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
Santos LH; Araújo AN; Fachini A; Pena A; Delerue-Matos C; Montenegro MC
J Hazard Mater; 2010 Mar; 175(1-3):45-95. PubMed ID: 19954887
[TBL] [Abstract][Full Text] [Related]
19. Prioritised pharmaceuticals in German estuaries and coastal waters: Occurrence and environmental risk assessment.
Kötke D; Gandrass J; Xie Z; Ebinghaus R
Environ Pollut; 2019 Dec; 255(Pt 1):113161. PubMed ID: 31541808
[TBL] [Abstract][Full Text] [Related]
20. Health effects and risks associated with the occurrence of pharmaceuticals and their metabolites in marine organisms and seafood.
Madikizela LM; Ncube S
Sci Total Environ; 2022 Sep; 837():155780. PubMed ID: 35537516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
